Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Kallik release white paper exploring how business rules can simplify the labelling and artwork management processes

Posted on: 23 Feb 18

Kallik explore how adopting a business rules engine can be the most effective approach to ensure labelling compliance while minimising the impact of new legislation.


Tamworth, UK – 22 February – Labelling and artwork management specialist, Kallik has released a new white paper, ‘A Rules Based Approach to Labelling and Artwork Management'. The paper discusses how organisations can eliminate many of the repetitive manual processes that consume unnecessary time and may lead to non-compliance through human error and fatigue.


The paper also explores the need to meet new requirements for e-Labelling, including introduction of the new EU MDR regulations coming into force May 2020.  These require labelling content to be published both electronically and in print and will place greater emphasis on labelling content being managed as re-usable digital assets. Added to this, companies are not only looking to enter new territories but also differentiate themselves in existing markets.  This all adds up to an increase in volume and complexity of product and market variations – something that manual, paper-based labelling processes will struggle to support. 


Kallik’s new white paper discusses the benefits of adopting a rules based approach to labelling and artwork. Commonly overlooked as more of a cost overhead rather than a core business activity, labelling and artwork errors can have serious consequences. Managing the decision-making process as a set of business rules allows for more responsive updates and revisions. It also ensures greater levels of consistency and helps shorten time to market.


The paper highlights the benefits of adopting a rules engine to underpin the labelling and artwork process and in particular the reduction of errors and increased levels of productivity, for heavily regulated industries such as pharmaceutical, chemical, cosmetic and medical device manufacturers. 

Editor's Details

Mike Wood

Last updated on: 23/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.